This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Technical University of Denmark, University of Copenhagen. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020-2021
Title: Innovations of Shamim Herbert Rahman
Introduction
Shamim Herbert Rahman is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of glycoproteins and their applications in medicine. With two patents to his name, Rahman's work focuses on enhancing the pharmacokinetic properties of proteins through innovative methods.
Latest Patents
Rahman's latest patents include "Production of N-glycoproteins for enzyme assisted glycomodification" and "N-glycosylation." The first patent relates to a cell that expresses a polypeptide of interest with specific posttranslational modification patterns. These modifications are crucial for improving pharmacokinetic properties, such as attaching PEG chains to proteins. The second patent involves a mammalian cell that also expresses a polypeptide of interest with posttranslational modifications, enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) in glycoprotein production.
Career Highlights
Throughout his career, Shamim Herbert Rahman has worked with prestigious institutions, including the University of Copenhagen and Danmarks Tekniske Universitet. His research has contributed to advancements in the field of glycoprotein production, making a significant impact on therapeutic applications.
Collaborations
Rahman has collaborated with esteemed colleagues such as Henrik Clausen and Zhang Yang. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Shamim Herbert Rahman is a distinguished inventor whose work in biotechnology has led to important advancements in glycoprotein production. His patents reflect a commitment to improving medical therapies through innovative scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile